Zdrowie i gospodarka · 18/11/2003

FDA Clears Diclofenac Potassium 25-Mg Tablets for Approval

The Food and Drug Administration (FDA) has determined that diclofenac potassium 25-milligram tablets, commonly known as Cataflam, were not withdrawn from sale due to safety or effectiveness concerns. This decision enables the FDA to approve abbreviated new drug applications for diclofenac potassium 25-mg tablets.